OruchR,PrymeIF,EngelsenBA,LundA, 2017.Neuroleptic malignant syndrome: An easily overlooked neurologic emergency,Neuropsychiatr Dis Treat 13 161 -75
NagelM,FreisbergS,JunghannsK,MollCK,WillenborgB, 2015.Das maligne neuroleptische syndrome (NMS) - Eine systematische ϋbersicht,[The neuroleptic malignant syndrome] Fortschr Neurol Psychiatr 83 373 -80
GerlachM,RiedererP,SchellerD., 2011.Mechanisms underlying and medical management of L-Dopa-associated motor complications,J Neural Transm 118 1659 -60
CaroffSN,MannSC, 1993.Neuroleptic malignant syndrome,Med Clin North Am 77 185 -202
ShalevA,HermeshH,Muntiz H, 1989.Mortality from neuroleptic malignant syndrome,J Clin Psychiatry 50 18 -
Al DanafJ,MadaraJ,DietscheC, 2015.Neuroleptic malignant syndrome: A case aimed at raising clinical awareness,Case Rep Med 769576 -
ButwickaA,KrystynaS,RetkaW,WolanczykT., 2014.Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency,Eur J Pediatr 173 1639 -42
SarkarP,NatarajanC,GodeN., 2009.Prevalence of neuroleptic malignant syndrome in 672 consecutive male in-patients,Indian J Psychiatry 51 202 -05
ChenPH,LaneHY,LinCH, 2016.Venous thromboembolism following dantrolene treatment for neuroleptic malignant syndrome,Clin Psychopharmacol Neurosci 14 399 -401
DavisJM,JanicakPG,SakkasP., 1991.Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome,Convuls Ther 7 111 -
ScheftnerWA,ShulmanRB, 1992.Treatment choice in neuroleptic malignant syndrome,Convuls Ther 8 267 -79
TrollorJN,SachdevPS,Z J, 1999.Electroconvulsive treatment of neuroleptic malignant syndrome: A review and report of cases, 33 650 -9
BuggenhoutS,VandenbergheJ,SienaertP., 2014.Electroconvulsion therapy for neuroleptic malignant syndrome,Tijdschr Psychiatr 56 612 -5